Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Innovative Treatment for Non-Muscle Invasive Bladder Cancer with Adstiladrin® at Fox Chase Cancer Center
Fox Chase Cancer Center is proud to be the first NCI designated Comprehensive Cancer Center in the Philadelphia region to offer Adstiladrin® as a groundbreaking therapy for non-muscle invasive bladder cancer (NMIBC). If you or a loved one are facing this diagnosis, and depending on the stage, type, and grade of your tumor, along with other factors, there may be a chance that Adstiladrin® could be the solution you've been searching for.
Understanding Adstiladrin®
Adstiladrin® is the first FDA-approved intravesical gene therapy for NMIBC. This innovative treatment is designed to target high-risk NMIBC that has not responded to traditional therapies like Bacillus Calmette-Guérin (BCG). Adstiladrin® works by delivering a copy of the interferon alfa-2b gene directly into the bladder.
Once inside, the gene is expressed locally, leading to the production of interferon alfa-2b protein. This protein has powerful anti-tumor effects, helping to eradicate cancer cells within the bladder.
What to Expect During Treatment
Treatment with Adstiladrin® is administered directly into the bladder using a catheter. Unlike traditional therapies that may require frequent administrations, Adstiladrin® is typically given once every three months, reducing the treatment burden on patients. While the therapy may require some additional precautions, our team will be with you every step of the way to ensure your comfort and safety.
Is Adstiladrin® Right for You?
If you have been diagnosed with high-risk NMIBC that has not responded to BCG therapy, Adstiladrin® may be an option worth exploring. Our team at Fox Chase Cancer Center is here to help you navigate your treatment options and determine the best course of action for your individual needs.
Why Choose Adstiladrin® at Fox Chase?
At Fox Chase Cancer Center, we are committed to providing our patients with the latest advancements in cancer treatment. Our team of experts are highly experienced in administering Adstiladrin® safely and effectively. With our state-of-the-art facilities and personalized approach to care, you can trust that you are in good hands at Fox Chase.
Take the Next Step
Ready to learn more about Adstiladrin® and how it could benefit you or a loved one? Contact us today to schedule a consultation with one of our experienced urologic oncologists. Together, we can explore your options and create a personalized treatment plan that gives you the best chance at beating bladder cancer.